Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Case ReportCase Reports and Clinical Observations

Atypical Presentation of Extramedullary Plasmacytoma

Eric Wallace, Zachary Stewart, David Theriot, William Shaffer, Shane Guillory, Michael Hanemann, Raman Danrad and Bradley Spieler
Ochsner Journal March 2018, 18 (1) 101-103;
Eric Wallace
1Department of Radiology, Louisiana State University Health Sciences Center, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary Stewart
2Department of Internal Medicine, Memorial Health University Medical Center, Savannah, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Theriot
3Department of Radiology, Emory University School of Medicine, Atlanta, GA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Shaffer
4Department of Radiology, Slidell Memorial Hospital, Slidell, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shane Guillory
5Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hanemann
1Department of Radiology, Louisiana State University Health Sciences Center, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raman Danrad
1Department of Radiology, Louisiana State University Health Sciences Center, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley Spieler
1Department of Radiology, Louisiana State University Health Sciences Center, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Plasmacytomas are monoclonal proliferations of plasma cells that typically affect the intramedullary axial skeleton. Imaging findings of an extramedullary plasmacytoma on radiograph and computed tomography can be nonspecific and can resemble other entities such as lymphoma, metastases, chondrosarcomas, or giant cell tumors.

Case Report: A 60-year-old female with a medical history of partial complex seizures, hypertension, diabetes, glaucoma, and hyperlipidemia presented with complaints of superficial abdominal pain associated with erythema and swelling for 3 weeks. Computed tomography of her abdomen at time of presentation revealed a 5.8 × 2.7-cm irregularly marginated soft-tissue density just below the umbilicus with an adjacent defect in the midline rectus abdominis. The final pathologic diagnosis was extramedullary plasmacytoma. Treatment during the next year included local radiation, systemic chemotherapy, and an autologous peripheral blood stem cell transplant. Three years after initial diagnosis, the patient presented to the emergency department, and testing revealed new plasmacytomas. The decision was made to proceed with palliative care.

Conclusion: This case is a unique example of a patient with an extramedullary plasmacytoma with no diagnostic signs of multiple myeloma.

Keywords
  • Multiple myeloma
  • plasmacytoma
  • soft tissue neoplasms

INTRODUCTION

Plasmacytomas are monoclonal proliferations of plasma cells that typically affect the intramedullary axial skeleton.1 In rare cases, they may occur first in soft tissues as focal proliferations of tissue and, in even rarer cases, may present as multiple nodules of soft-tissue density.2 Typically, multiple myeloma presents with cutaneous manifestations rather than cutaneous plasmacytomas degenerating into multiple myeloma.3 Imaging findings of an extramedullary plasmacytoma on radiograph and computed tomography (CT) can be nonspecific and can resemble other entities such as lymphoma, metastases, chondrosarcomas, or giant cell tumors.

CASE REPORT

A 60-year-old female with a medical history of partial complex seizures, hypertension, diabetes, glaucoma, and hyperlipidemia presented with complaints of superficial abdominal pain associated with erythema and swelling for 3 weeks. Physical examination revealed a scaly, indurated 9-cm diameter plaque with 4.5-cm central nodular erythematous tissue in the periumbilical abdomen. Laboratory data showed normal calcium (10.1 mg/dL), normal blood urea nitrogen and creatinine (18 mg/dL and 0.75 mg/dL, respectively), and no evidence of anemia.

CT scan of the patient's abdomen at the time of presentation revealed a 5.8 × 2.7-cm irregularly marginated soft-tissue density just below the umbilicus with an adjacent defect in the midline rectus abdominis (Figure 1). Preliminary pathology suggested lymphoma. Histologically, atypical mononuclear infiltrating fibroadipose and fibrocollagenous tissue and cells demonstrated foamy eosinophilic cytoplasm and oval to slightly irregular nuclear contours with rare Dutcher bodies. Cells were positive for CD79a, CD138, MUM1, and vimentin with kappa immunoglobulin (Ig) light chain restriction. Stain for Ki-67 showed a proliferation index within the tumor cells of 30%. Final pathologic diagnosis was extramedullary plasmacytoma.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Contrast-enhanced axial computed tomography images show a well-defined soft tissue mass just below the umbilicus.

Further workup, including skeletal survey radiograph and spine magnetic resonance imaging (MRI), demonstrated no evidence of metastases. Left iliac crest bone marrow biopsy was negative for multiple myeloma (12% plasma cells). The patient was started on focal radiation therapy (21 cycles) of the abdomen.

Approximately 6 months after completing radiation therapy for the abdominal mass, the patient developed a focal mass-like swelling on her right neck. Following ultrasound-guided biopsy, pathology returned another diagnosis of plasmacytoma. Positron emission tomography (PET)-CT identified an additional pathology-proven medullary plasmacytoma in the left femur that corresponded to a lucency noted on radiograph (Figure 2).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Radiographs demonstrate a moth-eaten/permeative pattern medially in the distal left femoral metadiaphysis with overlying cortical erosions and periosteal reaction.

During the next year, the patient was treated with local radiation to the left femur, systemic chemotherapy, and an autologous peripheral blood stem cell transplant. The patient's clinical course was complicated by the development of a pathologic fracture of the left femur treated with surgical hardware and multiple lower extremity deep vein thromboses treated with long-term oral anticoagulation. During this time, the patient's laboratory data showed normal beta-2 microglobulin and normal serum protein electrophoresis. Repeat bone marrow biopsies revealed normal hematopoiesis with plasma cells ranging from 7%-15%.

Three years after her initial diagnosis, the patient again presented to the emergency department complaining of multiple subcutaneous masses of the bilateral lower extremities. Evaluation with radiographs, CT, and biopsy revealed multiple new plasmacytomas in both thighs. Given the patient's poor functional status, multiple comorbid conditions, and progression of disease despite radiation, chemotherapy, and stem cell transplant, the decision was made to proceed with palliative care.

DISCUSSION

Plasmacytomas are differentiated into 4 basic categories: multiple myeloma, solitary bone plasmacytomas, extramedullary plasmacytomas, and extramedullary plasmacytomas in diffuse multiple myeloma.4 Multiple myeloma and solitary plasmacytoma are B-cell lymphoproliferative diseases composed of abnormal aggregates of plasma cells. The peak occurrence is in adults 50-60 years of age, and the male to female ratio is approximately 1.82:1 for solitary plasmacytoma.5 The annual incidence of myeloma is approximately 2-3 per 100,000 in the general population. Risk factors include exposure to ionizing radiation, herbicides, insecticides, and benzene.5 Solitary plasmacytoma is much less common; risk factors include exposure to ionizing radiation, herbicides, insecticides, and benzene.5 Solitary extramedullary plasmacytomas occur around the upper digestive tract in up to 85% of cases but can occur virtually anywhere.5,6 Incidence data for plasmacytoma, and more specifically solitary extramedullary plasmacytoma, are sparse given the rarity of the disease. Fewer than 30% of patients will progress to multiple myeloma, and approximately 37% disseminate past a single soft-tissue lesion.5,6 Genetic analysis of the tumor cells demonstrates abnormalities in band q32 of chromosome 14.7 Extramedullary plasmacytomas are commonly associated with polysomy and in approximately one-third of cases occur with a break in the long arm of chromosome 14, a slightly lower rate than in multiple myeloma. Ten percent to 20% of cases of extramedullary plasmacytoma can occur with a translocation at the 14th chromosome, t(4;14).8

Symptomatic plasmacytoma/myeloma presents with several common symptoms and laboratory findings. These findings include bone pain (65%), weakness and fatigue (50%), anemia (65%), renal insufficiency (20%), hypercalcemia (20%), marrow plasmacytosis >10% (90%), serum monoclonal Ig peak on standard electrophoresis (80%), or monoclonal Ig peak on immunofixation of serum or urine (97%).9

Diagnosis of myeloma is defined by major and minor criteria according to the Williams Manual of Hematology.9 Major criteria include plasmacytomas on tissue biopsy; marrow plasmacytosis with >30% plasma cells; monoclonal globulin spike on serum electrophoresis >3.5 g/dL for IgG or >2.0 g/dL for IgA; and 1.0 g/24 h of light-chain excretion on urine electrophoresis in the absence of amyloidosis. Minor criteria include marrow plasmacytosis 10%-30%; monoclonal globulin spike present but less than the levels defined in major criteria; lytic bone lesions; and normal IgM <0.05 g/dL, IgA <0.1 g/dL, or IgG <0.6 g/dL. Diagnosis of plasma cell myeloma is confirmed when one major and one minor criterion or 3 minor criteria are present in symptomatic patients with progressive disease. The presence of findings not specific for the disease, such as anemia, hypercalcemia, azotemia, bone demineralization, or hypoalbuminemia, supports the diagnosis.9 Multiple myeloma must be ruled out before making a diagnosis of solitary plasmacytoma and should be ruled out with a bone biopsy.

On initial CT imaging, the differential diagnosis includes lymphoma, chondrosarcoma, brown tumors, and giant cell tumors.10 General imaging considerations focus on the early use of MRI in evaluation of biopsy-proven lesions to exclude systemic disease. A finding of systemic spread would shift the diagnosis to multiple myeloma and require systemic chemotherapy for treatment.11

CT imaging is often indeterminate and shows a contrast-enhanced soft-tissue density mass with no identifiable matrix.10 The most helpful information is often location, as extramedullary plasmacytomas have a predilection for the upper gastrointestinal tract.10

Initial treatment of myeloma consists of chemotherapy and irradiation. Chemotherapy is an effective means of controlling the advancement of the disease process but may increase the risk of secondary leukemia. The commonly employed agents include melphalan and prednisone. Radiation to affected osseous sites may reduce pain and prevent vertebral collapse, deformity, and neural compression.7 In the absence of systemic disease, treatment includes 40-50 Gy radiotherapy in 20 fractions.12 Most patients are cured with local radiotherapy; however, lesions >5 cm are more likely to progress to systemic disease.13,14 Patients with solitary plasmacytoma have a 5-year survival rate of 60%. In contrast, patients with multiple myeloma have a 5-year survival rate of 18% and a median survival of 24 months.7

CONCLUSION

This case is a rare example of a patient with an extramedullary plasmacytoma with no diagnostic signs of multiple myeloma.

This article meets the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties Maintenance of Certification competencies for Patient Care and Medical Knowledge.

ACKNOWLEDGMENTS

The authors have no financial or proprietary interest in the subject matter of this article.

  • © Academic Division of Ochsner Clinic Foundation 2018

REFERENCES

  1. ↵
    1. Knowling MA.,
    2. Harwood AR.,
    3. Bergsagel DE.
    Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983 4; 1 4: 255- 262. pmid:6668499
    OpenUrlAbstract
  2. ↵
    1. Alvarez-Twose I.,
    2. Vano-Galvan S.,
    3. Calvo-Villas JM.,
    4. Carreter E.,
    5. Piqué E.,
    6. Palacios S.
    Metastatic cutaneous plasmacytoma presenting as a perianal giant mass. Dermatol Online J. 2008 9 15; 14 9: 17.
    OpenUrlPubMed
  3. ↵
    1. Varettoni M.,
    2. Corso A.,
    3. Pica G.,
    4. Mangiacavalli S.,
    5. Pascutto C.,
    6. Lazzarino M.
    Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol. 2010 2; 21 2: 325- 330. doi: 10.1093/annonc/mdp329. pmid:19633044
    OpenUrlCrossRefPubMed
  4. ↵
    1. Dimopoulos MA.,
    2. Kiamouris C.,
    3. Moulopoulos LA.
    Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am. 1999 12; 13 6: 1249- 1257. pmid:10626148
    OpenUrlCrossRefPubMed
  5. ↵
    1. Knobel D.,
    2. Zouhair A.,
    3. Tsang RW.,
    4. et al.
    Rare Cancer Network. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer. 2006 5 5; 6: 118. pmid:16677383
    OpenUrlCrossRefPubMed
  6. ↵
    1. Dores GM.,
    2. Landgren O.,
    3. McGlynn KA.,
    4. Curtis RE.,
    5. Linet MS.,
    6. Devesa SS.
    Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol. 2009 1; 144 1: 86- 94. doi: 10.1111/j.1365-2141.2008.07421.x. pmid:19016727
    OpenUrlCrossRefPubMed
  7. ↵
    1. Skinner HB.,
    2. McMahon PJ.
    Current Diagnosis & Treatment in Orthopedics. 5th ed. New York, NY: McGraw-Hill Education/Medical; 2013.
  8. ↵
    1. Bink K.,
    2. Haralambieva E.,
    3. Kremer M.,
    4. et al.
    Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica. 2008 4; 93 4: 623- 626. doi: 10.3324/haematol.12005. pmid:18326524
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Lichtman MA.,
    2. Kaushanksy K.,
    3. Kipps TJ.,
    4. Prchal JT.,
    5. Levi MM.
    Williams Manual of Hematology. 8th ed. New York, NY: McGraw-Hill Education/Medical; 2011.
  10. ↵
    1. Hall MN.,
    2. Jagannathan JP.,
    3. Ramaiya NH.,
    4. Shinagare AB.,
    5. Van den Abbeele AD.
    Imaging of extraosseous myeloma: CT, PET/CT, and MRI features. AJR Am J Roentgenol. 2010 11; 195 5: 1057- 1065. doi: 10.2214/AJR.10.4384. pmid:20966307
    OpenUrlCrossRefPubMed
  11. ↵
    1. Moulopoulos LA.,
    2. Granfield CA.,
    3. Dimopoulos MA.,
    4. Kim EE.,
    5. Alexanian R.,
    6. Libshitz HI.
    Extraosseous multiple myeloma: imaging features. AJR Am J Roentgenol. 1993 11; 161 5: 1083- 1087. pmid:8273615
    OpenUrlCrossRefPubMed
  12. ↵
    1. Kumar S.
    Solitary plasmacytoma: is radiation therapy sufficient? Am J Hematol. 2008 9; 83 9: 695- 696. doi: 10.1002/ajh.21248. pmid:18645990
    OpenUrlCrossRefPubMed
  13. ↵
    1. Ozsahin M.,
    2. Tsang RW.,
    3. Poortmans P.,
    4. et al.
    Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys. 2006 1 1; 64 1: 210- 217. pmid:16229966
    OpenUrlCrossRefPubMed
  14. ↵
    1. Soutar R.,
    2. Lucraft H.,
    3. Jackson G.,
    4. et al.
    Guidelines Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004 3; 124 6: 717- 726. pmid:15009059
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Ochsner Journal
Vol. 18, Issue 1
Mar 2018
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Atypical Presentation of Extramedullary Plasmacytoma
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Atypical Presentation of Extramedullary Plasmacytoma
Eric Wallace, Zachary Stewart, David Theriot, William Shaffer, Shane Guillory, Michael Hanemann, Raman Danrad, Bradley Spieler
Ochsner Journal Mar 2018, 18 (1) 101-103;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Atypical Presentation of Extramedullary Plasmacytoma
Eric Wallace, Zachary Stewart, David Theriot, William Shaffer, Shane Guillory, Michael Hanemann, Raman Danrad, Bradley Spieler
Ochsner Journal Mar 2018, 18 (1) 101-103;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rare Ocular Association With Hailey-Hailey Disease
  • Late Pancreatic Metastasis From Papillary Thyroid Carcinoma Diagnosed by Endoscopic Ultrasound-Guided Tissue Acquisition
  • Jarcho-Levin Syndrome With Fatal Respiratory Failure
Show more CASE REPORTS AND CLINICAL OBSERVATIONS

Similar Articles

Keywords

  • multiple myeloma
  • plasmacytoma
  • soft tissue neoplasms

Ochsner Journal Blog

Current Post

Be Careful Where You Publish -- Part 2

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2025 Ochsner Clinic Foundation

Powered by HighWire